mutLBSgeneDB

mutLBSgeneDB
mutated Ligand Binding Site gene DataBase

Home

Download

 Statistics

Help

About Us

Bioinformatics and Systems Medicine Laboratory Bioinformatics and Systems Medicine Laboratory

Gene Summary

Ligand Binding Site Mutation Information

Protein Structure Related Information

Gene Expression and Gene-Gene Network

Phenotype Information

Pharmacological Information

Conservation Information for LBS

Gene summary for HNF4A
Gene summary
Basic gene Info.Gene symbolHNF4A
Gene namehepatocyte nuclear factor 4, alpha
SynonymsFRTS4|HNF4|HNF4a7|HNF4a8|HNF4a9|HNF4alpha|MODY|MODY1|NR2A1|NR2A21|TCF|TCF14
CytomapUCSC genome browser: 20q13.12
Type of geneprotein-coding
RefGenesNM_000457.4,
NM_001030003.2,NM_001030004.2,NM_001258355.1,NM_001287182.1,
NM_001287183.1,NM_001287184.1,NM_175914.4,NM_178849.2,
NM_178850.2,
DescriptionHNF4alpha10/11/12TCF-14hepatic nuclear factor 4 alphahepatocyte nuclear factor 4-alphanuclear receptor subfamily 2 group A member 1transcription factor 14transcription factor HNF-4
Modification date20141222
dbXrefs MIM : 600281
HGNC : HGNC
Ensembl : ENSG00000101076
HPRD : 02612
Vega : OTTHUMG00000032531
ProteinUniProt: P41235
go to UniProt's Cross Reference DB Table
ExpressionCleanEX: HS_HNF4A
BioGPS: 3172
PathwayNCI Pathway Interaction Database: HNF4A
KEGG: HNF4A
REACTOME: HNF4A
Pathway Commons: HNF4A
ContextiHOP: HNF4A
ligand binding site mutation search in PubMed: HNF4A
UCL Cancer Institute: HNF4A
Assigned class in mutLBSgeneDBA: This gene has a literature evidence and it belongs to targetable_mutLBSgenes.
References showing study about ligand binding site mutation for HNF4A.1. "Arya VB, Rahman S, Senniappan S, Flanagan SE, Ellard S, Hussain K. HNF4A mutation: switch from hyperinsulinaemic hypoglycaemia to maturity-onset diabetes of the young, and incretin response. Diabet Med. 2014 Mar;31(3):e11-5. doi:10.1111/dme.12369. PubMed PMID: 24299156; PubMed Central PMCID: PMC4305198. " 24299156

Gene ontology having evidence of Inferred from Direct Assay (IDA) from Entrez
GO IDGO TermPubMed ID
GO:0006357regulation of transcription from RNA polymerase II promoter10330009
GO:0007596blood coagulation12911579
GO:0019216regulation of lipid metabolic process10551874
GO:0045893positive regulation of transcription, DNA-templated16488887
GO:0045944positive regulation of transcription from RNA polymerase II promoter7615825


Top
Ligand binding site mutations for HNF4A
Lollipop-style diagram of mutations at LBS in amino-acid sequence.
We represented ligand binding site mutations only. (You can see big image via clicking.)
 
: non-synonymous mutation on LBS, Circle size denotes number of samples.

Cancer type specific mutLBS sorted by frequency
LBSAAchange of nsSNVCancer type# samples
V199E200KBLCA1
R113R113GBRCA1
G69T68MCOAD1
R109D107YCOAD1
V199V199ICOAD1
R89V88LLUAD1
H92H92NLUAD1
C63G64VLUAD1
L213L213MLUAD1
C60A61PLUAD1
C60A58VLUAD1
H92,K90N91KOV1
R89R89QSKCM1
D135D135NSKCM1
C60A58TSTAD1
H92Y94HSTAD1
V199,K203W201RTHCA1
H92Y94CUCEC1
R116C115WUCEC1
D9D9NUCEC1
cf) Cancer type abbreviation. BLCA: Bladder urothelial carcinoma, BRCA: Breast invasive carcinoma, CESC: Cervical squamous cell carcinoma and endocervical adenocarcinoma, COAD: Colon adenocarcinoma, GBM: Glioblastoma multiforme, LGG: Brain lower grade glioma, HNSC: Head and neck squamous cell carcinoma, KICH: Kidney chromophobe, KIRC: Kidney renal clear cell carcinoma, KIRP: Kidney renal papillary cell carcinoma, LAML: Acute myeloid leukemia, LUAD: Lung adenocarcinoma, LUSC: Lung squamous cell carcinoma, OV: Ovarian serous cystadenocarcinoma, PAAD: Pancreatic adenocarcinoma, PRAD: Prostate adenocarcinoma, SKCM: Skin cutaneous melanoma, STAD: Stomach adenocarcinoma, THCA: Thyroid carcinoma, UCEC: Uterine corpus endometrial carcinoma.


Top
Protein structure related information for HNF4A
Relative protein structure stability change (ΔΔE) using Mupro 1.1
Mupro score denotes assessment of the effect of mutations on thermodynamic stability.
  (ΔΔE<0: mutation decreases stability, ΔΔE>0: mutation increases stability)
: nsSNV at non-LBS: nsSNV at LBS

nsSNVs sorted by the relative stability change of protein structure by each mutation
Blue: mutations of positive stability change. and red : the most recurrent mutation for this gene.
LBSAAchange of nsSNVRelative stability change
R113R113G-1.7656923
H92Y94H-1.4297622
R89R89Q-1.2431329
H92Y94C-1.1743606
V199E200K-1.1544839
V199W201R-1.073723
K203W201R-1.073723
K90N91K-1.0527065
H92N91K-1.0527065
L213L213M-0.97293049
D9D9N-0.97266091
R109D107Y-0.95366755
H92H92N-0.89794906
C60A58T-0.6543048
C60A61P-0.64222332
D135D135N-0.56276856
G69T68M-0.50804122
R89V88L-0.48239106
R116C115W-0.42649148
V199V199I-0.36762108
C60A58V-0.33282158
C63G64V-0.16182682
(MuPro1.1: Jianlin Cheng et al., Prediction of Protein Stability Changes for Single-Site Mutations Using Support Vector Machines, PROTEINS: Structure, Function, and Bioinformatics. 2006, 62:1125-1132)

Structure image for HNF4A from PDB

Top
Differential gene expression and gene-gene network for HNF4A
Differential gene expression between mutated and non-mutated LBS samples in all 16 major cancer types

Differential co-expressed gene network based on protein-protein interaction data (CePIN)
* Left PPI network was created from samples with mutations in the LBS of HNF4A and the right PPI network was created from samples without mutations in the LBS of HNF4A. Only genes with p-value < 0.05 are shown.
Red circle: input gene. Orange circle: LBSgene. Blue circle: other gene.


Top

Top
Phenotype information for HNF4A
Gene level disease information (DisGeNet)
Disease IDDisease name# PubMedAssociation type
umls:C0011860Diabetes Mellitus, Type 2141Biomarker, GeneticVariation
umls:C0342276Mason-Type Diabetes83Biomarker
umls:C1852093Maturity-Onset Diabetes of the Young, Type 17Biomarker, GeneticVariation
umls:C0009324Colitis, Ulcerative7Biomarker, GeneticVariation

Mutation level pathogenic information (ClinVar annotation)
Allele IDAA changeClinical significanceOriginPhenotype IDs

Top
Pharmacological information for HNF4A
Gene expression profile of anticancer drug treated cell-lines (CCLE)
Heatmap showing the correlation between gene expression and drug response across all the cell-lines. We chose the top 20 among 138 drugs.We used Pearson's correlation coefficient.

Gene-centered drug-gene interaction network
Drug information targeting mutLBSgene (Approved drugs only)
Drug statusDrugBank IDNameTypeDrug structure
InvestigationalDB05447AVI-4557Small molecule
ExperimentalDB08231MYRISTIC ACIDSmall molecule

Gene-centered ligand-gene interaction network

Ligands binding to mutated ligand binding site of HNF4A go to BioLip
Ligand IDLigand short nameLigand long namePDB IDPDB namemutLBS


Top
Conservation information for LBS of HNF4A
Multiple alignments for P41235 in multiple species
LBSAA sequence# speciesSpecies
C60GVSALCAICGD3Homo sapiens, Mus musculus, Rattus norvegicus
C63ALCAICGDRAT3Homo sapiens, Mus musculus, Rattus norvegicus
C77YGASSCDGCKG3Homo sapiens, Mus musculus, Rattus norvegicus
C80SSCDGCKGFFR3Homo sapiens, Mus musculus, Rattus norvegicus
D135VQNERDRISTR3Homo sapiens, Mus musculus, Rattus norvegicus
D214CELLLDDQVAL2Mus musculus, Rattus norvegicus
D214CELPLDDQVAL1Homo sapiens
D78GASSCDGCKGF3Homo sapiens, Mus musculus, Rattus norvegicus
D9SKTLVDMDMAD1Homo sapiens
D9SKTLAGMDMAD1Mus musculus
D9SKTLADMDMAD1Rattus norvegicus
E133EAVQNERDRIS3Homo sapiens, Mus musculus, Rattus norvegicus
E27AYTTLEFENVQ3Homo sapiens, Mus musculus, Rattus norvegicus
E372DNLLQEMLLGG3Homo sapiens, Mus musculus, Rattus norvegicus
F208KYIPAFCELLL2Mus musculus, Rattus norvegicus
F208KYIPAFCELPL1Homo sapiens
F83DGCKGFFRRSV3Homo sapiens, Mus musculus, Rattus norvegicus
G377EMLLGGSASDA2Mus musculus, Rattus norvegicus
G377EMLLGGSPSDA1Homo sapiens
G69GDRATGKHYGA3Homo sapiens, Mus musculus, Rattus norvegicus
G79ASSCDGCKGFF3Homo sapiens, Mus musculus, Rattus norvegicus
H71RATGKHYGASS3Homo sapiens, Mus musculus, Rattus norvegicus
H92SVRKNHMYSCR3Homo sapiens, Mus musculus, Rattus norvegicus
I137NERDRISTRRS3Homo sapiens, Mus musculus, Rattus norvegicus
K203LVEWAKYIPAF3Homo sapiens, Mus musculus, Rattus norvegicus
K70DRATGKHYGAS3Homo sapiens, Mus musculus, Rattus norvegicus
K81SCDGCKGFFRR3Homo sapiens, Mus musculus, Rattus norvegicus
K90RRSVRKNHMYS3Homo sapiens, Mus musculus, Rattus norvegicus
L196MKEQLLVLVEW3Homo sapiens, Mus musculus, Rattus norvegicus
L213FCELLLDDQVA2Mus musculus, Rattus norvegicus
L213FCELPLDDQVA1Homo sapiens
L220DQVALLRAHAG3Homo sapiens, Mus musculus, Rattus norvegicus
L369AKIDNLLQEML3Homo sapiens, Mus musculus, Rattus norvegicus
M373NLLQEMLLGGS3Homo sapiens, Mus musculus, Rattus norvegicus
N110DKDKRNQCRYC3Homo sapiens, Mus musculus, Rattus norvegicus
N368MAKIDNLLQEM3Homo sapiens, Mus musculus, Rattus norvegicus
Q131KKEAVQNERDR3Homo sapiens, Mus musculus, Rattus norvegicus
Q216LLLDDQVALLR2Mus musculus, Rattus norvegicus
Q216LPLDDQVALLR1Homo sapiens
R109VDKDKRNQCRY3Homo sapiens, Mus musculus, Rattus norvegicus
R113KRNQCRYCRLK3Homo sapiens, Mus musculus, Rattus norvegicus
R116QCRYCRLKKCF3Homo sapiens, Mus musculus, Rattus norvegicus
R134AVQNERDRIST3Homo sapiens, Mus musculus, Rattus norvegicus
R136QNERDRISTRR3Homo sapiens, Mus musculus, Rattus norvegicus
R221QVALLRAHAGE3Homo sapiens, Mus musculus, Rattus norvegicus
R66AICGDRATGKH3Homo sapiens, Mus musculus, Rattus norvegicus
R85CKGFFRRSVRK3Homo sapiens, Mus musculus, Rattus norvegicus
R86KGFFRRSVRKN3Homo sapiens, Mus musculus, Rattus norvegicus
R89FRRSVRKNHMY3Homo sapiens, Mus musculus, Rattus norvegicus
S138ERDRISTRRSS3Homo sapiens, Mus musculus, Rattus norvegicus
S43Homo sapiens, Mus musculus, Rattus norvegicus
V130MKKEAVQNERD3Homo sapiens, Mus musculus, Rattus norvegicus
V199QLLVLVEWAKY3Homo sapiens, Mus musculus, Rattus norvegicus
V217LLDDQVALLRA2Mus musculus, Rattus norvegicus
V217PLDDQVALLRA1Homo sapiens
Y72ATGKHYGASSC3Homo sapiens, Mus musculus, Rattus norvegicus


Copyright © 2016-Present - The University of Texas Health Science Center at Houston
Site Policies | State of Texas